Diagnostic value of serum thyroglobulin measurements in the follow-up of differentiated thyroid carcinoma, a structured meta-analysis.
about
Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid CancerCurrent status and future perspectives in differentiated thyroid cancer2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid CancerClinical Outcome of Remnant Thyroid Ablation with Low Dose Radioiodine in Korean Patients with Low to Intermediate-risk Thyroid CancerSystematic reviews of diagnostic tests in endocrinology: an audit of methods, reporting, and performance.Long-term consequence of elevated thyroglobulin in differentiated thyroid cancer.Identifying a risk profile for thyroid cancer.Limited adequacy of thyroid cancer patient follow-up at a Canadian tertiary care centre.Markedly elevated thyroglobulin levels in the preoperative thyroidectomy patient correlates with metastatic burden.Preablation Stimulated Thyroglobulin/TSH Ratio as a Predictor of Successful I(131)Remnant Ablation in Patients with Differentiated Thyroid Cancer following Total Thyroidectomy.The stratification of patient risk depending on the size and ratio of metastatic lymph nodes in papillary thyroid carcinoma.Prognostic significance of the number of metastatic lymph nodes to stratify the risk of recurrence.Accuracy of positron emission tomography and positron emission tomography-CT in the detection of differentiated thyroid cancer recurrence with negative (131) I whole-body scan results: A meta-analysis.Diagnostic Whole-Body Scan May Not Be Necessary for Intermediate-Risk Patients with Differentiated Thyroid Cancer after Low-Dose (30 mCi) Radioactive Iodide Ablation.Overwhelming rapid metabolic and structural response to apatinib in radioiodine refractory differentiated thyroid cancer.Evaluation of whole-body retention of iodine-131 ((131)I) after postoperative remnant ablation for differentiated thyroid carcinoma - thyroxine withdrawal versus rhTSH administration: A retrospective comparison.Response: Diagnostic Whole-Body Scan May Not Be Necessary for Intermediate-Risk Patients with Differentiated Thyroid Cancer after Low-Dose (30 mCi) Radioactive Iodide Ablation (Endocrinol Metab 2014;29:33-9, Eon Ju Jeon et al.).Platelet derived growth factor receptor alpha mediates nodal metastases in papillary thyroid cancer by driving the epithelial-mesenchymal transition.Thyroglobulin as early prognostic marker to predict remission at 18-24 months in differentiated thyroid carcinoma.Stimulated Serum Thyroglobulin Levels versus Unstimulated Serum Thyroglobulin in the Follow-up of Patients with Papillary Thyroid Carcinoma.Additional value of a high sensitive thyroglobulin assay in the follow-up of patients with differentiated thyroid carcinoma.Biochemical Testing in Thyroid Disorders.
P2860
Q26829349-59942328-E051-4393-B143-AFB586BEAA1FQ27024484-F99AD042-88E8-4141-9FBE-FEFF9EEE4E1BQ30367068-43A71255-14E2-4E1E-B29F-25B74BF4F1DCQ35778563-5C7217E5-C60D-47CD-9A28-7D3EE23A1331Q36393699-9397257B-8AB0-4FCF-A28E-2AFD1B62BBF7Q36515458-368CA83F-D5A7-4B27-A57C-FCE02FE24830Q36949776-624216B9-108A-4178-B0F8-1F8C19A0D520Q37384821-A54946FA-8753-4DA5-8E40-45983463A992Q37428853-989EEE26-20AA-4BD2-B9F1-3D2E76F7CB5BQ37724978-AD091C68-FDE1-432B-B7ED-DDCBC47E72B3Q37736769-F90C1DBB-719C-4651-9B93-1F823CC31D69Q38168704-DEDE7C9B-050E-4E7B-8518-6029DF8B90F3Q38253900-D9F88CAB-FBE1-49A2-ADDC-17D2274D703FQ38563685-C928DFDA-D5D5-4354-AAAC-05C9BE573326Q41091965-FCEEE45B-B082-4476-9548-1DEC17D8035AQ41771255-2E9AE37B-07A7-4432-8A31-83B6BC5426EDQ41881203-DE3CF75A-A188-4E08-8925-53B8C7A2BE2EQ41968021-5908F6A3-FF57-4E91-BB92-ED1747793DCBQ43746499-B147581C-D2C8-4645-8FBF-FC2B6A36CA88Q49336881-EC38F19A-E21E-4112-9F50-38CE92CFA3FFQ51536755-AA599F5D-5BE6-4132-83E5-D7360A215BD3Q55164859-FEC31A61-5D1E-4DEF-8DE0-82951CBEB0BA
P2860
Diagnostic value of serum thyroglobulin measurements in the follow-up of differentiated thyroid carcinoma, a structured meta-analysis.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Diagnostic value of serum thyr ...... a, a structured meta-analysis.
@en
Diagnostic value of serum thyr ...... a, a structured meta-analysis.
@nl
type
label
Diagnostic value of serum thyr ...... a, a structured meta-analysis.
@en
Diagnostic value of serum thyr ...... a, a structured meta-analysis.
@nl
prefLabel
Diagnostic value of serum thyr ...... a, a structured meta-analysis.
@en
Diagnostic value of serum thyr ...... a, a structured meta-analysis.
@nl
P2093
P2860
P1476
Diagnostic value of serum thyr ...... a, a structured meta-analysis.
@en
P2093
Eustatia-Rutten CF
Pereira AM
Stokkel MP
van der Kleij-Corssmit EP
P2860
P356
10.1111/J.1365-2265.2004.02060.X
P577
2004-07-01T00:00:00Z